Logo image of BH

BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

USA - NYSE:BH - US08986R3093 - Common Stock

360.86 USD
+4.7 (+1.32%)
Last: 10/17/2025, 8:04:00 PM
363.048 USD
+2.19 (+0.61%)
After Hours: 10/17/2025, 8:04:00 PM
Fundamental Rating

4

Overall BH gets a fundamental rating of 4 out of 10. We evaluated BH against 135 industry peers in the Hotels, Restaurants & Leisure industry. While BH has a great health rating, its profitability is only average at the moment. BH has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BH had positive earnings in the past year.
BH had a positive operating cash flow in the past year.
In multiple years BH reported negative net income over the last 5 years.
BH had a positive operating cash flow in each of the past 5 years.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.57%, BH is in the better half of the industry, outperforming 63.70% of the companies in the same industry.
BH has a Return On Equity of 6.70%. This is in the better half of the industry: BH outperforms 61.48% of its industry peers.
BH has a worse Return On Invested Capital (2.23%) than 68.15% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BH is significantly below the industry average of 10.67%.
Industry RankSector Rank
ROA 4.57%
ROE 6.7%
ROIC 2.23%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 10.47%, BH is in the better half of the industry, outperforming 78.52% of the companies in the same industry.
BH has a worse Operating Margin (5.21%) than 61.48% of its industry peers.
BH's Operating Margin has improved in the last couple of years.
BH's Gross Margin of 38.13% is on the low side compared to the rest of the industry. BH is outperformed by 65.93% of its industry peers.
BH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.21%
PM (TTM) 10.47%
GM 38.13%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BH is destroying value.
Compared to 1 year ago, BH has about the same amount of shares outstanding.
Compared to 5 years ago, BH has less shares outstanding
The debt/assets ratio for BH is higher compared to a year ago.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.42 indicates that BH is not in any danger for bankruptcy at the moment.
BH has a Altman-Z score of 3.42. This is in the better half of the industry: BH outperforms 77.04% of its industry peers.
The Debt to FCF ratio of BH is 1.42, which is an excellent value as it means it would take BH, only 1.42 years of fcf income to pay off all of its debts.
BH's Debt to FCF ratio of 1.42 is amongst the best of the industry. BH outperforms 87.41% of its industry peers.
BH has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
BH has a better Debt to Equity ratio (0.14) than 79.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.42
Altman-Z 3.42
ROIC/WACC0.27
WACC8.23%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BH has a Current Ratio of 1.38. This is a normal value and indicates that BH is financially healthy and should not expect problems in meeting its short term obligations.
BH has a Current ratio of 1.38. This is in the better half of the industry: BH outperforms 67.41% of its industry peers.
A Quick Ratio of 1.35 indicates that BH should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.35, BH is doing good in the industry, outperforming 70.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.35
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

BH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 310.05%, which is quite impressive.
Looking at the last year, BH shows a small growth in Revenue. The Revenue has grown by 4.14% in the last year.
The Revenue for BH have been decreasing by -11.55% on average. This is quite bad
EPS 1Y (TTM)310.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.18%
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.62, which indicates a rather cheap valuation of BH.
Based on the Price/Earnings ratio, BH is valued cheaply inside the industry as 99.26% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.40. BH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.62
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BH is valued a bit cheaper than the industry average as 60.74% of the companies are valued more expensively.
BH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BH is cheaper than 85.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.27
EV/EBITDA 10.65
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIGLARI HOLDINGS INC-B

NYSE:BH (10/17/2025, 8:04:00 PM)

After market: 363.048 +2.19 (+0.61%)

360.86

+4.7 (+1.32%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-06 2025-11-06
Inst Owners88.79%
Inst Owner Change0.35%
Ins Owners0.4%
Ins Owner Change0%
Market Cap822.76M
Analysts43.33
Price TargetN/A
Short Float %30.89%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.62
Fwd PE N/A
P/S 2.18
P/FCF 13.27
P/OCF 9.5
P/B 1.4
P/tB 1.6
EV/EBITDA 10.65
EPS(TTM)137.55
EY38.12%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)27.19
FCFY7.54%
OCF(TTM)37.98
OCFY10.53%
SpS165.43
BVpS258.46
TBVpS225.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 6.7%
ROCE 2.67%
ROIC 2.23%
ROICexc 2.72%
ROICexgc 3.1%
OM 5.21%
PM (TTM) 10.47%
GM 38.13%
FCFM 16.44%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexcg growth 3Y-14.08%
ROICexcg growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.42
Debt/EBITDA 1.34
Cap/Depr 59.46%
Cap/Sales 6.52%
Interest Coverage 250
Cash Conversion 141.88%
Profit Quality 156.94%
Current Ratio 1.38
Quick Ratio 1.35
Altman-Z 3.42
F-Score5
WACC8.23%
ROIC/WACC0.27
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)310.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%289.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.14%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-30.96%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.73%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y-30.77%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%